Deferoxamine

Deferoxamine

SCHEMBL8720384

CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN.[PbH2]

nearest known ligand 0.97

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ KDM4A O75164 8/20 0.97
▸ HIF1A Q16665 1/20 0.97
▸ TET2 Q6N021 1/20 0.97
▸ DOHH Q9BU89 1/20 0.97
▸ KDM4E B2RXH2 1/20 0.90
▸ LMNA P02545 1/20 0.90
▸ GAA P10253 1/20 0.90
▸ SMN1; SMN2 Q16637 1/20 0.90
▸ PAOX Q6QHF9 3/20 0.45
▸ SLC6A5 Q9Y345 2/20 0.43
▸ KDM4C Q9H3R0 7/20 0.39
▸ CASP2 P42575 1/20 0.37
▸ KDM5A P29375 1/20 0.36
▸ KDM7A Q6ZMT4 1/20 0.36
▸ PHF8 Q9UPP1 1/20 0.36
▸ KDM2A Q9Y2K7 1/20 0.36
▸ NAAA Q02083 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21051754 0.99 KDM4A (1.00) KDM4AHIF1ATET2DOHHKDM4E
SCHEMBL26511991 0.99 KDM4A (1.00) KDM4AHIF1ATET2DOHHKDM4E
SCHEMBL17100575 0.99 KDM4A (1.00) KDM4AHIF1ATET2DOHHKDM4E
SCHEMBL17109729 0.99 KDM4A (1.00) KDM4AHIF1ATET2DOHHKDM4E
SCHEMBL19040665 0.99 KDM4A (1.00) KDM4AHIF1ATET2DOHHKDM4E
Deferoxamine SCHEMBL10498260 0.99 KDM4A (1.00) KDM4AHIF1ATET2DOHHKDM4E
SCHEMBL13367139 0.99 KDM4A (1.00) KDM4AHIF1ATET2DOHHKDM4E
Deferoxamine SCHEMBL34571 0.99 KDM4A (1.00) KDM4AHIF1ATET2DOHHKDM4E
Deferoxamine SCHEMBL20658962 0.97 KDM4A (0.97) KDM4AHIF1ATET2DOHHKDM4E
Deferoxamine SCHEMBL21049242 0.97 KDM4A (0.97) KDM4AHIF1ATET2DOHHKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1998020905-A2 TREATMENT OF IRON OVERLOAD DISORDERS BIOMEDICAL FRONTIERS, INC. (US) 1998-05-22 — — WO disclosed
Send feedback